Clovis Oncology, Inc.

Company Listings from SPi: Clovis Oncology, Inc.

You are here: Home >> SPi Company Listings >> Clovis Oncology, Inc.


Clovis Oncology, Inc.


Search for other references to "clovis" on SPi News

Latest Clovis Oncology, Inc. News

Clovis Oncology Announces Pricing of Public Offerings of Convertible Senior Notes and Common Stock Clovis Oncology, Inc. (NASDAQ:CLVS) announced today the upsizing and pricing of an underwritten public offering of 0 million aggregate principal amount of...... 01:54 GMT Tuesday 17th April 2018

Clovis Oncology Initiates Early Access Program for Rucaparib as Treatment and as Maintenance Therapy in Recurrent Ovarian Cancer in Europe Clovis Oncology, Inc. (NASDAQ:CLVS) today announced the initiation of an early access program in Europe for rucaparib for treatment and as maintenance therapy...... 12:52 GMT Friday 23rd March 2018

CHMP Grants Positive Opinion for Clovis Oncology’s Rubraca® (rucaparib) Tablets Clovis Oncology, Inc. (NASDAQ: CLVS) today announced that the European Union’s (EU) European Medicines Agency (EMA) Committee for Medicinal Products for Hum...... 12:50 GMT Friday 23rd March 2018

Clovis Oncology Submits Supplemental New Drug Application for Rucaparib as Maintenance Treatment for Patients with Platinum-Sensitive Recurrent Ovarian Cancer Clovis Oncology (NASDAQ: CLVS) announced today that the company has submitted a supplemental New Drug Application (sNDA) to the U.S. Food and Drug Administrat...... 21:05 GMT Monday 9th October 2017

Clovis Oncology’s Rucaparib ARIEL3 Study Data Published in The Lancet Clovis Oncology, Inc. (NASDAQ: CLVS) announced that comprehensive data from the Phase 3 ARIEL3 study of rucaparib for maintenance treatment of advanced ovaria...... 11:00 GMT Wednesday 13th September 2017

Clovis Oncology’s Rucaparib Significantly Improved Progression-Free Survival in All Ovarian Cancer Patient Populations Studied in Phase 3 ARIEL3 Maintenance Treatment Trial Clovis Oncology, Inc. (NASDAQ: CLVS) today announced topline data from the confirmatory phase 3 ARIEL3 trial of rucaparib, which successfully achieved the pri...... 08:45 GMT Monday 19th June 2017

Trading of Clovis Oncology, Inc. Common Stock Halted Clovis Oncology, Inc. (NASDAQ: CLVS) today announced that NASDAQ has halted trading of the Company’s common stock. The U.S. Food and Drug Administration’s...... 12:04 GMT Tuesday 12th April 2016

Buy Clovis Oncology, Inc.
Market Reports
from SPi

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2018. [Admin Only]
Sector Publishing Intelligence Ltd.
Ground Floor Offices, Little Keep Gate, Barrack Road, Dorchester, Dorset DT1 1AH
Registered in England and Wales number 0751938.
Privacy Policy | Terms and Conditions | Contact Us

Advertising on SPi News: Information For Advertisers